AstraZeneca plans its largest manufacturing investment in Virginia, reported from Cambridge.
2 reports, 2 independent
Updated Jul 29
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca plans its largest manufacturing investment in Virginia, reported from Cambridge.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AstraZeneca is investing $4.5 billion in a new manufacturing campus near Charlottesville, Virginia.Sub-event
AstraZeneca announced plans for its largest manufacturing investment in Virginia.1 source
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Virginia
human settlement in Argentina
Related events
- AstraZeneca and Teva Pharmaceutical Industries Limited are being compared as large-cap healthcare companies regarding their revenue and earnings.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.
- AstraZeneca plans a $2B facility in Tuas, Singapore, while President Shanmugaratnam conducts a state visit to Sweden.
Coverage
Newest first; wire copies grouped- Business WireAstraZeneca results: H1 and Q2 2025 Strong growth momentum continues with excellent R&D pipeline delivery in the year-to-date CAMBRIDGE, England, July 29, 2025--(BUSINESS WIRE)--AstraZeneca: Revenue
- Simply Wall St.AstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030 AstraZeneca recently announced plans to invest $50 billion in the U.S. by 2030, including the development of a major manufacturing